OneThree Biotech Email Format
Biotechnology ResearchNew York, United States2-10 Employees
OneThree Biotech is a biotechnology research firm based in New York City, born from the largest precision medicine institute in America. It seeks to lower the failure rate of bringing therapeutics to market by applying biology-driven artificial intelligence calibrated to real-world results. The company collaborates with major biotech and pharmaceutical partners to validate predictions in areas such as target discovery, therapeutic identification, toxicity forecasting, and biomarker selection, with examples including a prediction later validated in a Phase II trial for Oncoceutics' ONC201. OneThree's target customers are biotech and pharma partners seeking AI-guided biology to accelerate drug discovery and development. In 2022, the company formed a collaboration with Poolbeg Pharma to build a tailored AI model using Poolbeg's RSV data, illustrating an active external partnership.